Search

Search Constraints

You searched for: Author/Creator Amato, S.

Search Results

1. Centrality determination in heavy-ion collisions with the LHCb detector. (1st May 2022)

2. Identification of charm jets at LHCb. (1st February 2022)

3. Latent tuberculosis infection in patients with chronic plaque psoriasis: evidence from the Italian Psocare Registry. (17th March 2015)

4. Latent tuberculosis infection in patients with chronic plaque psoriasis: evidence from the Italian Psocare Registry. (1st June 2015)

5. Measurement of CP observables in B± → DK*± decays using two- and four-body D final states. (November 2017)

6. PSOCUBE, a multidimensional assessment of psoriasis patients as a both clinically/practically sustainable and evidence‐based algorithm. (4th November 2014)

7. Search for the doubly heavy baryons and decaying to and *We acknowledge support from CERN and from the national agencies: CAPES, CNPq, FAPERJ and FINEP (Brazil); MOST and NSFC (China); CNRS/IN2P3 (France); BMBF, DFG and MPG (Germany); INFN (Italy); NWO (Netherlands); MNiSW and NCN (Poland); MEN/IFA (Romania); MSHE (Russia); MICINN (Spain); SNSF and SER (Switzerland); NASU (Ukraine); STFC (United Kingdom); DOE NP and NSF (USA). We acknowledge the computing resources that are provided by CERN, IN2P3 (France), KIT and DESY (Germany), INFN (Italy), SURF (Netherlands), PIC (Spain), GridPP (United Kingdom), RRCKI and Yandex LLC (Russia), CSCS (Switzerland), IFIN-HH (Romania), CBPF (Brazil), PL-GRID (Poland) and NERSC (USA). We are indebted to the communities behind the multiple open-source software packages on which we depend. Individual groups or members have received support from ARC and ARDC (Australia); AvH Foundation (Germany); EPLANET, Marie Skłodowska-Curie Actions and ERC (European Union); A*MIDEX, ANR, Labex P2IO and OCEVU, and Région Auvergne-Rhône-Alpes (France); Key Research Program of Frontier Sciences of CAS, CAS PIFI, CAS CCEPP, Fundamental Research Funds for the Central Universities, and Sci. Tech. Program of Guangzhou (China); RFBR, RSF and Yandex LLC (Russia); GVA, XuntaGal and GENCAT (Spain); the Leverhulme Trust, the Royal Society and UKRI (United Kingdom). (September 2021)